The FDA has approved Orkambi, a new combination drug for patients aged 12 and older suffering from the most common form of cystic fibrosis.
Health · Videos · Feature
FDA clears drug for leading form of cystic fibrosis
Jul 3, 2015 5 min read By MyMazaa Editorial